Syed Mohammad Ali Kazmi1 article listing Syed Mohammad Ali Kazmi in Nature Communications, indexed by Paperzzz from Crossref and OSF.Domvanalimab plus zimberelimab in unresectable and immunotherapy refractory biliary tract cancers: a phase 2 trial Nature Communications